Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein. [electronic resource]
Producer: 20200316Description: 3685-3696 p. digitalISSN:- 1097-4652
- ATP Binding Cassette Transporter, Subfamily B -- genetics
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Calcium-Binding Proteins -- genetics
- Cell Proliferation -- drug effects
- Down-Regulation
- Doxorubicin -- metabolism
- Drug Resistance, Neoplasm
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Flavonols -- pharmacology
- G2 Phase Cell Cycle Checkpoints
- Gene Expression Regulation, Neoplastic
- Humans
- K562 Cells
- Leukemia -- drug therapy
- Ondansetron -- pharmacology
- Proto-Oncogene Proteins c-akt -- metabolism
- Signal Transduction
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.